Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2 Studies
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Interleukin-2 (IL-2) is a protein found naturally in the blood that helps boost the immune
system. The purpose of this study is to provide long-term treatment and monitoring of HIV
infected people enrolled in NIAID-funded studies investigating the use of laboratory-made
IL-2 for the treatment of HIV infection.
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)